MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517058963 A) filed by Eli Lilly And Company; and Chugai Seiyaku Kabushiki Kaisha, Indianapolis, on June 19, for 'process to make glp1 ra and intermediates therefor.'
Inventor(s) include Allian, Ayman D; Berglund, Kenneth Derek; Cole, Kevin Paul; Davis, Ashlee Jeanette; Hess, Molly; Jemison, Adrianna; Kerr, Mark Steven; Mack, Audrey Grace; Ortiz-Medina, Xavier A.; Remick, David Michael; Starkey, Derek Robert; Vaid, Radhe Krishan; Yang, Qiang; Kawagishi, Fumiki; Emura, Takashi; Tsuchiya, Satoshi; Wadamoto, Manabu; and Yamawaki, Minoru.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds."
The patent application was internationally filed on Dec. 18, 2023, under International application No.PCT/US2023/084487.
Disclaimer: Curated by HT Syndication.
